SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001390777-17-000022
Filing Date
2017-02-03
Accepted
2017-02-03 12:50:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 RevanceTherapeutics.txt SC 13G/A 49825
  Complete submission text file 0001390777-17-000022.txt   51424
Mailing Address 225 LIBERTY STREET NEW YORK NY 10286
Business Address 225 LIBERTY STREET NEW YORK NY 10286 212-495-1784
Bank of New York Mellon Corp (Filed by) CIK: 0001390777 (see all company filings)

IRS No.: 132614959 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88023 | Film No.: 17571159
SIC: 2834 Pharmaceutical Preparations